Literature DB >> 24842632

Concomitant persistent pain in classical trigeminal neuralgia--evidence for different subtypes.

Stine Maarbjerg1, Aydin Gozalov, Jes Olesen, Lars Bendtsen.   

Abstract

OBJECTIVE: To describe the clinical characteristics in classical trigeminal neuralgia (TN) with concomitant persistent pain and to investigate whether TN with concomitant persistent pain represents a distinct phenotype.
BACKGROUND: There has been much debate about the possible pathophysiological and clinical importance of concomitant persistent pain in TN. This has led to subgrouping of TN into forms with and without concomitant persistent pain in the recent 3rd International Classification of Headache Disorders beta classification.
METHODS: In this cross-sectional study, data on the clinical characteristics were systematically and prospectively collected from consecutive TN patients.
RESULTS: A total of 158 consecutive TN patients were included. Concomitant persistent pain was present in 78 patients (49%). The average intensity of concomitant persistent pain was 4.6 (verbal numerical rating scale). The concomitant persistent pain was present at onset or early in the disease course. Patients with concomitant persistent pain were on average 6.2 (P = .008) years younger at onset, but the 2 groups had the same duration of disease (P = .174). There was a preponderance of women in TN with (P < .001) but not in TN without concomitant persistent pain (P = .820). Right-sided pain was more prevalent than left-sided in TN without (P = .007) but not in TN with concomitant persistent pain (P = .907). TN with concomitant persistent pain more frequently had sensory abnormalities (P < .001) and less frequently responded to sodium channel blockers (P = .001). There were no significant differences in other clinical characteristics.
CONCLUSIONS: Concomitant persistent pain is very prevalent in TN and is not a consequence of paroxysmal pain. Findings support that the 3rd International Classification of Headache Disorders beta division of TN with and without concomitant persistent pain is clinically and scientifically important.
© 2014 American Headache Society.

Entities:  

Keywords:  concomitant persistent pain; diagnostic criteria; field-testing; trigeminal neuralgia

Mesh:

Year:  2014        PMID: 24842632     DOI: 10.1111/head.12384

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  14 in total

Review 1.  The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Authors:  Shannon M Smith; Robert H Dworkin; Dennis C Turk; Ralf Baron; Michael Polydefkis; Irene Tracey; David Borsook; Robert R Edwards; Richard E Harris; Tor D Wager; Lars Arendt-Nielsen; Laurie B Burke; Daniel B Carr; Amy Chappell; John T Farrar; Roy Freeman; Ian Gilron; Veeraindar Goli; Juergen Haeussler; Troels Jensen; Nathaniel P Katz; Jeffrey Kent; Ernest A Kopecky; David A Lee; William Maixner; John D Markman; Justin C McArthur; Michael P McDermott; Lav Parvathenani; Srinivasa N Raja; Bob A Rappaport; Andrew S C Rice; Michael C Rowbotham; Jeffrey K Tobias; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2017-02-27       Impact factor: 5.820

Review 2.  Idiopathic Facial Pain Syndromes–An Overview and Clinical Implications.

Authors:  Christian Ziegeler; Thomas Beikler; Martin Gosau; Arne May
Journal:  Dtsch Arztebl Int       Date:  2021-02-12       Impact factor: 5.594

3.  Trigeminal neuralgia--a coherent cross-specialty management program.

Authors:  Tone Heinskou; Stine Maarbjerg; Per Rochat; Frauke Wolfram; Rigmor Højland Jensen; Lars Bendtsen
Journal:  J Headache Pain       Date:  2015-07-17       Impact factor: 7.277

4.  The temporal evolution of a facial pain syndrome associated with neurovascular contact: a case report.

Authors:  Sabrina Khan; Ida Wibrandt; Per Rochat; Messoud Ashina
Journal:  J Headache Pain       Date:  2015-02-11       Impact factor: 7.277

5.  Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial.

Authors:  Hsing-Yu Weng; Anna S Cohen; Christoph Schankin; Peter J Goadsby
Journal:  Cephalalgia       Date:  2017-11-02       Impact factor: 6.292

6.  Trigeminal Neuralgia: Basic and Clinical Aspects.

Authors:  Erika Ivanna Araya; Rafaela Franco Claudino; Elcio Juliato Piovesan; Juliana Geremias Chichorro
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 7.  Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.

Authors:  G Di Stefano; A Truini; G Cruccu
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

8.  A Case of Trigeminal Neuralgia Treated With Combination of Antihistamine, Montelukast, and Corticosteroid Nasal Spray.

Authors:  Asna Shahab; Mydah S Hashmi; Zahoor Ahmed; Agha S Haider; Aimen Haider
Journal:  Cureus       Date:  2020-12-22

9.  P2X3 receptor upregulation in trigeminal ganglion neurons through TNFα production in macrophages contributes to trigeminal neuropathic pain in rats.

Authors:  Momoko Koizumi; Sayaka Asano; Akihiko Furukawa; Yoshinori Hayashi; Suzuro Hitomi; Ikuko Shibuta; Katsuhiko Hayashi; Fusao Kato; Koichi Iwata; Masamichi Shinoda
Journal:  J Headache Pain       Date:  2021-04-26       Impact factor: 7.277

Review 10.  Schwann cells and trigeminal neuralgia.

Authors:  Jia-Yi Liao; Tian-Hua Zhou; Bao-Kang Chen; Zeng-Xu Liu
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.